Parkman Healthcare Partners LLC Immunic, Inc. Transaction History

Parkman Healthcare Partners LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.97 - $1.6 $446,442 - $736,400	-460,250 Reduced 81.82%	102,256 $153,000
Q3 2023 Nov 14, 2023	BUY	$1.35 - $2.87 $30,716 - $65,301	22,753 Added 4.22%	562,506 $826,000
Q2 2023 Aug 11, 2023	BUY	$1.33 - $2.51 $106,377 - $200,757	79,983 Added 17.4%	539,753 $1.35 Million
Q4 2022 Feb 13, 2023	SELL	$1.13 - $10.8 $223,596 - $2.14 Million	-197,873 Reduced 30.09%	459,770 $643,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $22,845 - $41,806	7,615 Added 1.17%	657,643 $2.08 Million
Q2 2022 Aug 12, 2022	SELL	$3.13 - $12.25 $1.37 Million - $5.38 Million	-439,223 Reduced 40.32%	650,028 $2.26 Million
Q1 2022 May 13, 2022	BUY	$9.54 - $14.26 $1.1 Million - $1.64 Million	115,068 Added 11.81%	1,089,251 $12.3 Million
Q4 2021 Feb 11, 2022	BUY	$7.34 - $10.25 $367,704 - $513,484	50,096 Added 5.42%	974,183 $9.32 Million
Q3 2021 Nov 12, 2021	BUY	$8.05 - $13.29 $4.11 Million - $6.78 Million	510,000 Added 123.16%	924,087 $8.18 Million
Q2 2021 Aug 13, 2021	BUY	$11.76 - $16.85 $151,339 - $216,842	12,869 Added 3.21%	414,087 $5.08 Million
Q1 2021 May 14, 2021	BUY	$14.21 - $25.3 $490,628 - $873,533	34,527 Added 9.42%	401,218 $6.4 Million
Q4 2020 Feb 12, 2021	SELL	$14.8 - $20.37 $493,313 - $678,972	-33,332 Reduced 8.33%	366,691 $5.61 Million
Q3 2020 Nov 13, 2020	BUY	$11.74 - $22.0 $3.05 Million - $5.72 Million	260,023 Added 185.73%	400,023 $7.43 Million
Q2 2020 Aug 13, 2020	BUY	$5.67 - $15.86 $793,800 - $2.22 Million	140,000 New	140,000 $1.7 Million

51.2M

824K

354K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $38.8M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.